Cyclohexane

Cyclohexane

SCHEMBL357093

C1CCCCC1.COC(C)(C)C

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.73
TSHR P16473 2/20 0.36
TDP1 Q9NUW8 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8679785 0.85 ALDH1A1 (1.00) ALDH1A1TSHRTDP1
SCHEMBL6223 0.85
SCHEMBL503396 0.85
Cyclohexane SCHEMBL2480141 0.83 ALDH1A1 (0.50) ALDH1A1TSHR
SCHEMBL1921973 0.80 ALDH1A1 (0.47) ALDH1A1
SCHEMBL3664027 0.80
Water SCHEMBL10335432 0.80
SCHEMBL3662439 0.80
Hydrochloric Acid SCHEMBL3840624 0.80
Water SCHEMBL2652847 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024046279-A1 POLYMORPH OF MAO-B INHIBITOR PRODRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF 广州市恒诺康医药科技有限公司 2024-03-07 WO claimed
CN-117623989-A Polymorphic form of MAO-B inhibitor prodrug, and preparation method and application thereof 广州市恒诺康医药科技有限公司 2024-03-01 CN claimed
WO-2024046279-A1 POLYMORPH OF MAO-B INHIBITOR PRODRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF 广州市恒诺康医药科技有限公司 2024-03-07 WO disclosed
CN-117623989-A Polymorphic form of MAO-B inhibitor prodrug, and preparation method and application thereof 广州市恒诺康医药科技有限公司 2024-03-01 CN disclosed
CN-111433336-B Odorants and compositions comprising odorants 丝趣科尔卡有限公司 2024-02-23 CN disclosed
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 US disclosed
CN-117120052-A Substituted 4- ([ 1,2,4] triazolo [1,5-a ] pyridin-6-yl) thiophene-2-carboxamide derivatives and uses thereof 约翰斯·霍普金斯大学 2023-11-24 CN disclosed
CN-111448299-B Odorants and compositions comprising odorants 丝趣科尔卡有限公司 2023-10-31 CN disclosed
US-20230296514-A1 Zinc-Selective Fluorescent Probes for Emission-Ratiometric Imaging GEORGIA TECH RESEARCH CORPORATION 2023-09-21 US disclosed
CN-110382473-B Hydrophobic compounds for optically active devices 爱尔兰眼力健公司 2023-08-15 CN disclosed
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed
US-5280036-A Containing 4h-1,24-triazole ring BASF AKTIENGESELLSCHAFT (DE) 1994-01-18 US disclosed
US-5214064-A Insecticides, nematocides, miticides BASF AKTIENGESELLSCHAFT (DE) 1993-05-25 US disclosed
US-5187182-A Insecticides, nematocides BASF AKTIENGESELLSCHAFT (DE) 1993-02-16 US disclosed
US-5185359-A N-phenoxphenyloxymethyl substituted azoles and method for controlling pests therewith BASF AKTIENGESELLSCHAFT (DE) 1993-02-09 US disclosed
WO-1992020669-A1 PROCESSES FOR THE DIASTEREOSELECTIVE SYNTHESIS OF NUCLEOSIDES BIOCHEM PHARMA INC. (CA) 1992-11-26 WO disclosed
US-5116860-A N-SUBSTITUTED AZOLES FOR COMBATING INSECTS, ARACHNIDS AND NEMATODES BASF AKTIENGESELLSCHAFT (DE) 1992-05-26 US disclosed
US-4943584-A (p-Phenoxyphenoxy)-methyl-five-membered hetaryls BASF AKTIENGESELLSCHAFT (DE) 1990-07-24 US disclosed
US-4943585-A N-substituted azoles and insecticide, arachnicide, and nematocide compositions thereof BASF AKTIENGESELLSCHAFT (DE) 1990-07-24 US disclosed
US-4851440-A ASTHMA HOECHST AKTIENGESELLSCHAFT (DE) 1989-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 ALDH1A1 1851/4885TSHR 3882/4885TDP1 3811/4885
US-20230296514-A1 Zinc-Selective Fluorescent Probes for Emission-Ratiometric Imaging ZRANB2, ZFR, SLC30A6 ALDH1A1 1651/4885TSHR 3730/4885TDP1 2996/4885
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF SNCA, PSEN2, PARK7 ALDH1A1 821/4885TSHR 1230/4885TDP1 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.